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Objective: To study whether there are fac-
tors related to secondary diagnoses (SDg)
present in patients with prostate cancer that influence the
development of urinary incontinence after radical
 prostatectomy (RP).
Materials and methods: A retrospective multicenter observa-
tional study was performed reviewing the medical records of
430 men who underwent RP due to organ-confined prostate
cancer in 9 different hospitals. Two study groups were
 distinguished: Group A (GA): Patients without urinary
 incontinence after RP; Group B (GB): patients with any degree
of post-surgical urinary incontinence.
Results: Average age at surgery was 63.42 years (range 
45-73). 258 patients were continent after surgery and 172
patients complaint of any degree of incontinence after RP. 
A higher percentage of healthy patients was found in group A
(continent after surgery) than in group B (p = 0.001). 
The most common SDg prior to surgery were hypertension,
lower urinary tract symptoms, dyslipidemia, diabetes mellitus
and erectile dysfunction, but none did show a greater trend
towards post-surgical incontinence.
Conclusions: A better health status prior to surgery is associ-
ated to a lower incidence of new-onset urinary incontinence
after radical prostatectomy. However, no correlation was
found between the most common medical disorders and the
development of post-surgical urinary incontinence. 
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dence of tumour cells in the prostate (1), a 9.5% will
have risk of being diagnosed with prostate cancer
throughout their life, and 3% of them will have the prob-
ability of dying due to this disease (2, 3). Histological
signs of prostate cancer have been found in 42% of
patients who died due to other causes (4, 5).
Most prostate cancers are organ-confined at diagnosis (6).
When the patient's life expectancy is 10 years or greater
and his health status is compatible with general anaesthe-
sia, radical prostatectomy achieves the best results in
oncological terms (7). Radical prostatectomy is a complex
major surgery, which requires dissection and removal of
all the prostate gland and disruption and modification of
a large part of the anatomical structures that makes up the
male sphincteric complex. The different muscles, liga-
ments and neurovascular elements of the sphincteric
complex converge in the prostate apex, in an anatomical
funnel, whose upper limit is the prostate gland. The
development of urinary incontinence (UI) is one of its
most feared complications and is attributed to the techni-
cal characteristics of the surgery. The factors that may be
associated to an increased risk of developing UI after sur-
gery have been studied, i.e, ageing and deliberate wide
resection of the cavernous nerves.
The aim of this study was to evaluate whether there are
factors related to secondary diagnoses (SDg) present in
patients that influence the development of UI after radi-
cal prostatectomy (RP). 
MATERIALS AND METHODS
A retrospective multicenter observational study was per-
formed. Medical records of 430 men who underwent RP
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INTRODUCTION
Studies performed in autopsies objectify that up to 30-
40% of men aged 50 or older will show histological evi-
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due to organ-confined prostate cancer were reviewed.
Patients were treated at the University Hospital of
Salamanca (Spain), University Hospital Pêro da Covilhã
(Covilhã, Portugal), University Hospital and Hospital of
Coimbra (Portugal), University Hospital Virgen del Camino
(Pamplona, Spain), University Hospital Complex of Ourense
(Spain), University Hospital Puerta del Mar (Cádiz, Spain)
and University Hospital Integrated Trust Of Verona (Italy).
The sample selection was obtained from patients who
underwent RP due to organ-confined prostate cancer in the
above mentioned health care centres. December 2011 was
the date used as reference and cases were selected sequen-
tially in succession and retrospectively. Open and laparo-
scopic RP were performed routinely at the centres involved
in the study, but robot-assisted RP was performed in only
one centre and in all cases by the same surgeon.
For our purposes, we collected the information from the
patients' medical records of the following variables:
– patient-related variables: Age, BMI, personal history,
SDg, ASA score, prostate volume;
– disease-related variables: PSA at diagnosis, Gleason
score of the biopsy, percentage of affected cores, pres-
ence of HG-PIN or atypical small acinar proliferation
(ASAP), cTNM and pTNM, Gleason score of the surgi-
cal specimen, affectation of surgical margins;
– surgery-related variables: Centre of intervention, surgi-
cal technique (open, laparoscopic or robot-assisted),
intervention's duration, age and experience of surgeon,
surgical bleeding, post-surgical complications.
Post-prostatectomy UI was described as any leakage of
urine, not present prior to the surgery. Patients without
any secondary diagnosis were considered healthy.
Patients receiving adjuvant or salvage radiation therapy
were excluded from the study.
Two study groups were distinguished: Group A (GA):
Patients without urinary incontinence after radical
prostatectomy; Group B (GB): patients with any degree
of urinary incontinence after radical prostatectomy
requiring pads. Patients from GB were stratified accord-
ing to the UI severity: mild ≤ 100cc/24 hours; moderate
101-400cc/24 hours and severe > 401cc/24 hours
according to Pad Test.
The results were analyzed with descriptive statistics, t-
distribution, Chi2, Fisher's exact test, ANOVA analysis of
variance (with Scheffe's test for normal samples and
Kruskal-Wallys for other distributions), Pearson's and
Spearman's correlation studies. Statistical significance at
p < 0.05 was accepted.
The study was approved by the Research Committee of the
University Hospital of Salamanca, Spain. All ethical, legal
and regulatory requirements for research on human sub-
jects were considered, meeting the ethical principles for
medical research of the Declaration of Helsinki.
RESULTS
Average age at the moment of the surgery was 63.42
years (SD 5.67, range 45-73). 258 patients were conti-
nent after surgery (Group A) and 172 patients complaint
of any degree of incontinence after RP (Group B).
Table 1 shows the general characteristics of patients and
of the disease in GA and GB.
Surgical technique
The technique most commonly performed was laparo-
scopic RP with 217 patients, follow by 190 open RP, and
23 robot-assisted RP (these were all performed at the same
centre and by the same surgeon). 56.31% of patients after
open RP were continent, as well as 61.29% after laparo-
scopic RP and 91.30% after robot-assisted RP.
Table 1. 
General characteristics of the patient and of the tumour in the whole sample and for groups A and B.
Group A Group B p Others
Age 62.87 (SD 6.09) 64.34 (SD 4.57) 0.26 Total GA+GB = 63.42 (SD 5.67)
BMI 28.56 (SD 3.59) 27.96 (SD 5.26) 0.55 Total GA+GB = 28.83 (SD 4.32)
ASA 2.01 (SD 0.52) 2.00 (SD 0.52) 0.93
PSA 8.61 (SD 4.37) 8.78 ( SD 4.14) 0.85
Prostate volume 41.37 (SD 12.59) 41.18 (SD18.66) 0.81 Measured during prostate biopsy
Gleason biopsy 6.13 (SD 0.61) 6.52 (SD 0.74) 0.00
Tumour burden (% affected cylinders) 15.56 (SD 2.02) 16.40 (SD 2.53) 0.78
c TNM 7.23 (SD 4.02) 6.75 (SD 3.70) 0.11 *
P TNM 3.27 (SD 1.69) 3.35 (SD 1.56) 0.74 **
SD: Standard deviation of the mean. 
* Clinical or pre-surgical TNM was codified as: 1 - T1, 2 - T1a, 3 - T1b, 4 - T1c, 5 - cT1c, 6 - T2, 7 - T2a, 8 - T2b, 9 - T2c, 10 - cT2a, 11 - cT2b, 12 - cT2c, 13 - T3a, 14 - T4. 
** Pathological TNM after the intervention or pTNM was codified as: 1 - pT2a, 2 - pT2b, 3 - pT2c, 4 - pT3a, 5 - pT3b, 6 - pT3c, 7 - pT2, 8vpT3.
Table 2. 
Most common secondary diagnoses (≥ 10%) 
in the whole sample.
SDg in the whole sample Type N %
(n = 430)
HTN 182 42.32




Dyslipidemia General 109 25.34
Hypercholesterolemia 35 8.13
Diabetes mellitus General 56 13.02
NIDDM 28 6.51
IDDM 6 1.39
HTN: arterial hypertension. LUTS: lower urinary tract symptoms. 
BPH: benign prostatic hyperplasia. NIDDM: noninsulin-dependent diabetes mellitus. 
IDDM insulin-dependent diabetes mellitus.
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Secondary diagnoses
Only 76 (17.67%) out of 430 patients were healthy,
without any SDg. 
The most common SDg were hypertension (HTN), lower
urinary tract symptoms (LUTS), dyslipidemia, diabetes
mellitus (DM) and erectile dysfunction (ED). Their distri-
bution in the whole sample and in groups A and B are
shown in Tables 2 and 3. A higher percentage of healthy
patients was found in group A (continent after surgery)
than in group B, difference that was statistically significant.
Table 4 shows the distribution of other SDg in the whole
sample.
DISCUSSION
LUTS infections, functional and cognitive impairment,
neurological disorders and prostatectomy (8) are consid-
ered risk factors for UI in older men.
In men in the study, considering the age and without
prostatectomy, less than 1% would have some degree of
urinary incontinence. A prevalence of up to 40.77% was
observed in the 6 weeks following the surgery. 
Incontinence is described as any leakage of urine that
was not present prior to the surgery. 33.33% had severe
urinary incontinence, 27.45% moderate incontinence
and 39.22% mild incontinence.
This prevalence is higher than that reported in the liter-
ature: 0-11% for minimally invasive prostatectomy and
3-20% for open surgery (9). This discordance may be
due to the used UI definition: any leakage of urine, no
matter how scarce or transitory it is, which was not pres-
ent before. Data were recorded in the first consultation
after surgery. A trend to improvement of the results of
continence was observed during all the follow-up time,
until 48.12 months. At 24 months, only 26.7% of
patients suffered from some degree of incontinence.
These results were closer than those reported by other
authors.
Second diagnoses and urinary incontinence 
after radical prostatectomy 
The prevalence of SDg in the sample does not differ from
that observed in the general population. The most com-
mon are HTN, LUTS, dyslipidemia and DM (42.32%,
31.62%, 25.34% and 13.02% respectively).
LUTS and DM have been associated to the risk for UI in
men, related to radical prostatectomy but also without
prostatectomy history (10, 11).
DM has been proposed as an independent factor for the
development of urinary incontinence. It is usually asso-
ciated to age over 65 and to the use of insulin as mark-
ers of severity (11, 12). In our series is noteworthy that
the prevalence of DM in the group of incontinent
patients (2.90%) is lower than in the group of continents
(13.56%) (p < 0.0001). DM type 2 or noninsulin-
dependent DM was the most common in the sample, and
it had a shorter evolution time than DM type 1. These
data are important since both the evolution time and the
intrinsic insulin deficiency have been proposed as deter-
minants of axonal damage that eventually causes loss of
urine in elderly patients (13, 14).
14.22% of patients were diabetic, from which 77.89%
had DM type 2 with a similar pattern of distribution in
the groups A and B (78.21% in group A and 76.35% in
group B).
LUTS prior to the RP has also been reported as a risk fac-
tor for developing urinary incontinence (8, 15).
Neuroanatomical abnormalities in structures related to
male sphincter complex would lead to a series of modi-
fications that would predispose to suffer UI after prosta-
tectomy. These abnormalities could be caused either by
a trabeculated bladder, used to withstand high filling
 pressures (with consequent fibromuscular, irreversible
damage) in relation to a distal obstructive element (usu-
ally BPH) or by a primary hypo- or hypertonic bladder
(much less common).
Table 3. 
Most common secondary diagnoses in GA and GB. 
Disease Group A Group B P
n % n %
None: healthy 61 23.64 15 8.72 0.001
HTN 96 37.20 66 38.37 0.8393
DM 35 13.56 5 2.90 0.0001
ED previous to prostatectomy 13 5.04 10 5.81 0.8275
Dyslipidemia 56 21.70 44 25.58 0.3541
Table 4. 
Other SDg in the whole sample.
Other SDg Type N %
in the whole sample 
(n = 430)
Urological Relative with prostate cancer 6 1.39
Bladder cancer 4 0.93
Erectile dysfunction 27 6.27
Hydrocele 4 0.93
Phimosis 6 1.39
Neurological Cerebrovascular accident 7 1.62
Sequels of meningitis or cerebral palsy 5 1.16
Pituitary adenoma 3 0.69
Osteoarticular Herniated disc 26 6.04
Ankylosing spondylitis 3 0.69
Hip prosthesis 6 1.39
Respiratory Asthma 12 2.79
COPD 7 1.62
OSAS 14 3.25
Cardiac Coronary artery disease 12 2.79
Valvular heart disease 11 2.56
Arrhythmia: AF 8 1.86
Hepatopathology Steatosis 11 2.56
Idiopathic 8 1.86
Chronic with portal hypertension 5 1.16
Gastrointestinal Esophagitis 6 1.39
Gastritis 15 3.48
Peptic ulcer 7 1.62
Hiatal hernia 8 1.86
Irritable bowel 4 0.93
Colon polyps 6 1.39
Haemorrhoids 8 1.86
Obesity (BMI > 30) 21 4.88
Hyperuricemia 28 6.51
Chronic renal failure under dialysis 6 1.39
Depression 29 6.74
Sense organs Glaucoma 11 2.56
Hearing loss 14 3.25
Vertigo 3 0.69
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In our series, 31.62% of patients had some degree of
LUTS with an average IPSS of 8.23 points (mild). It was
measured in the consultation, by protocol and prior to
the surgery, as well as the flowmetry. The flowmetry was
performed in 88.34% of the patients included in the
study and in 92.98% of patients classified as suffering
from LUTS; it showed an average of 9.33 ml/min
(obstructive). Epidemiological data (men over 60 years),
the rate of prostate symptoms and urinary flow results
suggest a tendency to suffer obstructive LUTS.
The results after surgery vary in this subgroup of
patients. Patients with any degree of UI after RP are sim-
ilar regarding affectation by LUTS in the groups of mild,
moderate and severe incontinence (35.29%, 32.60% and
33.04% respectively) (p = 0.88). Therefore, suffering
from LUTS prior to RP would not be related to the pres-
ence of IU after RP. A sphincter complex used to filling
and emptying pressures higher than normal could be
more prepared than a normal sphincter complex to the
aggression of the RP, as the first has a tendency to hyper-
pressure and hypertrophy. 
Broader studies would be necessary to investigate these
pathophysiological aspects.
Regarding the presence of affected margins in the surgi-
cal piece, only the results from one centre (level 4 pub-
lic hospital) could be studied. It contributed to the sam-
ple with 153 cases. Affected margin was defined as the
surgical piece in which tumour cells are less than 2 mm
from the stain with Indian ink of the edge (16). No dif-
ference between GA (24.04%) and GB (25.71%) (p =
0.4344) was observed in this centre regarding the affec-
tation of margins, as it has been previously reported by
this research group (17).
The absence of SDg or patients with better health con-
dition was associated with not suffering any degree of UI
after RP (23.64% in GA versus 8.72% in GB, p < 0.001).
This finding is consistent with other published results
(9, 12).
Erectile dysfunction prior to the surgery has been pro-
posed as a risk factor for IU after RP (18). The hypothe-
sis that erectile dysfunction is associated to sensorineur-
al deficits or to a worse overall condition of sphincter
complex structures could explain this relationship with
UI (19).
In our series, there was no difference in the distribution
of hypertension and erectile dysfunction between GA
and GB (Table 4).
CONCLUSIONS
Age, body mass index, having diabetes mellitus, hyper-
tension or symptoms of lower urinary tract prior to the
surgery do not influence the development of urinary
incontinence after radical prostatectomy.
However, a better health condition expressed as absence
of disease is associated to a lower incidence of new-onset
urinary incontinence after radical prostatectomy.
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